Amalgamated Bank Has $15.60 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Amalgamated Bank lowered its stake in CME Group Inc. (NASDAQ:CME) by 2.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 70,679 shares of the financial services provider’s stock after selling 2,037 shares during the quarter. Amalgamated Bank’s holdings in CME Group were worth $15,595,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of CME. Y.D. More Investments Ltd acquired a new stake in shares of CME Group in the second quarter worth $36,000. Thurston Springer Miller Herd & Titak Inc. grew its stake in CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after acquiring an additional 74 shares in the last quarter. McClarren Financial Advisors Inc. increased its holdings in shares of CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the period. Asset Dedication LLC lifted its position in shares of CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares in the last quarter. Finally, New Covenant Trust Company N.A. acquired a new stake in shares of CME Group during the first quarter worth approximately $82,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ CME opened at $225.19 on Wednesday. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a market cap of $81.09 billion, a P/E ratio of 23.68, a P/E/G ratio of 5.62 and a beta of 0.55. The business’s 50 day moving average is $221.24 and its two-hundred day moving average is $209.67.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the firm earned $2.25 EPS. The business’s revenue was up 18.4% on a year-over-year basis. On average, equities analysts expect that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.04%. CME Group’s dividend payout ratio (DPR) is 48.37%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on CME shares. Morgan Stanley upped their price objective on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Keefe, Bruyette & Woods increased their price objective on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. The Goldman Sachs Group upped their target price on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Piper Sandler raised their price target on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Finally, Citigroup boosted their price target on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research note on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $222.73.

Insiders Place Their Bets

In other news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the sale, the director now directly owns 25,067 shares in the company, valued at approximately $5,587,935.64. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other CME Group news, Director Timothy S. Bitsberger sold 1,000 shares of the company’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total transaction of $226,960.00. Following the transaction, the director now directly owns 10,589 shares in the company, valued at approximately $2,403,279.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Martin J. Gepsman sold 400 shares of CME Group stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the sale, the director now owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is currently owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.